How to releasing results is what our NASH 700 strategy is about IMO. We want to release to doctors and researchers who will say, this is something, not to investors, some of who have other agendas than supporting CYDY.

Two strategies in play here, one during the Pandemic was the right one, NP's put it out there in a CC during the Pandemic was the right move, but in the endemic stage, the current move of being careful how you release results, unless it's Long Haulers, is the right move. What we are looking at is Pandemic strategy vs post Pandemic strategy.